The host response in different aetiologies of community-acquired pneumonia: Potential new targets for adjunctive treatments?
Open Access
- 15 July 2022
- journal article
- editorial
- Published by Elsevier in EBioMedicine
- Vol. 82, 104140
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The host response in different aetiologies of community-acquired pneumoniaEBioMedicine, 2022
- Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trialThe Lancet Respiratory Medicine, 2021
- Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guidelineEuropean Respiratory Journal, 2021
- Endothelial Responses in SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Corticosteroids as adjunctive therapy in the treatment of influenzaCochrane Database of Systematic Reviews, 2019
- Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?Seminars in Respiratory and Critical Care Medicine, 2016
- Pneumonia and risk of venous thrombosis: results from the MEGA studyJournal of Thrombosis and Haemostasis, 2012